Ramsay Santé reports a 3.3% increase in revenue to €2.6bn, driven by growth in France and the Nordics. EBITDA remains stable at €285m, with net loss reduced to €35m. The company serves 13 million patients in five countries, focusing on innovation and operational excellence. A new contract in Sweden worth €4.8bn has been successfully initiated.

CEO Pascal Roché highlights solid revenue growth and stable profitability, despite challenges in French revenue guarantee. The company remains committed to innovation and operational excellence to drive sustainable growth. The Board of Directors approved the consolidated financial statements for the period ended 31 December 2025.

Key performance indicators (KPIs) for the half-year ending December 2025 show revenue growth of 3.3% to €2,589.1m, with EBITDA at €284.8m. Operating profit, net leverage, and net loss have all shown improvements compared to the previous year. The company continues to focus on financial discipline and growth.

Half-year financial results reveal a stable EBITDA of €284.8m, with operating profit at €62.7m. The company has managed to offset cost inflation through productivity efforts and cost control. Net financial debt stands at €3,757.1m, with restated net leverage improving to 5.3x. Ramsay Santé is committed to delivering high-quality, innovative healthcare.

The company’s mission-driven approach has resulted in continuous improvement in care pathways, including medicine, surgery, obstetrics, mental health, and primary care. Ramsay Santé’s strategic roadmap focuses on investment in innovation, operational excellence, and rigorous financial management to ensure equitable access to quality care across Europe.

Read more at GlobeNewswire: Half-year results at the end of December